Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000019617-25-000528·JPMORGAN CHASE & CO
Schedule 13G ownership disclosure
Karyopharm Therapeutics Inc
Common Stock, $0.0001 par value · CUSIP: 48576U205
Event date: 2025-06-30
- Filing-level shares
- 450,436.0
- Percent of class
- 5.2%
- JPMORGAN CHASE & CO.
Shares: 450,436.0 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000528
- Form type
- SCHEDULE 13G
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- Jul 16, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership